Insider Monkey
Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline
📈
AI Sentiment
Highly Positive
8/10
Roivant Sciences Ltd. News
Latest updates and market news for ROIV
2 news
Dec 31 - Jan 6, 2026
Page 1
MT Newswires
Roivant Sciences Insider Sold Shares Worth $28,902,500, According to a Recent SEC Filing
📉
AI Sentiment
Negative
3/10
Share this news page